• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
ALA

AROVELLA THERAPEUTICS LIMITED - Announcements

5.71% ! 9.9¢
Market Cap $118.1M  !

Arovella Therapeutics Limited is a biotechnology company. The Company is focused on... Arovella Therapeutics Limited is a biotechnology company. The Company is focused on developing its invariant natural killer T (iNKT) cell therapy platform from Imperial College London to treat blood cancers and solid tumors. The Company's lead product is ALA-101. ALA-101 is being developed as an allogeneic cell therapy, which means it can be given from a healthy donor to a patient. ALA-101 is a next-generation CAR-iNKT cell therapy that targets CD19+ B cell lymphomas and leukemias. ALA-101 consists of CAR19-iNKT cells that have been modified to produce a Chimeric Antigen Receptor (CAR) that targets CD19. CD19 is an antigen found on the surface of numerous cancer types. The Company is also engaged in expanding solid tumor treatment through its CLDN18.2-targeting technology licensed from Sparx Group. Its iNKT cells also contain an invariant T cell receptor (iTCR) that targets alpha-galactosylceramide (a-GalCer) bound CD1d, another antigen found on the surface of several cancer types.More

Announcements



ALA Dr John Maher Appointed to SUDA iNKT Cell Therapy SAB03/09/21 download Created with Sketch. 147.85KB
ALA Preliminary Final ReportPRICE SENSITIVE31/08/21 download Created with Sketch. 291.67KB
ALA Dr Reuben Benjamin Appointed to SUDA iNKT Cell Therapy SABPRICE SENSITIVE26/08/21 download Created with Sketch. 171.78KB
ALA SUDA signs Licence and Distribution Agreement with STADAPRICE SENSITIVE24/08/21 download Created with Sketch. 202.74KB
ALA ZolpiMist UpdatePRICE SENSITIVE23/08/21 download Created with Sketch. 143.74KB
ALA iNKT cell therapy platform updatePRICE SENSITIVE16/08/21 download Created with Sketch. 178.02KB
ALA Initial Director's Interest Notice12/08/21 download Created with Sketch. 136KB
ALA Appointment of Dr Debora Barton as Non-Executive Director10/08/21 download Created with Sketch. 148.16KB
ALA SUDA appoints new cell and gene therapy manufacturing expertPRICE SENSITIVE02/08/21 download Created with Sketch. 218.78KB
ALA SUDA to present at NWR Virtual Investor Conference29/07/21 download Created with Sketch. 148.09KB
ALA Quarterly Appendix 4C and Activities ReportPRICE SENSITIVE26/07/21 download Created with Sketch. 305.08KB
ALA Notification regarding unquoted securities - SUD13/07/21 download Created with Sketch. 37.64KB
ALA Application for quotation of securities - SUD29/06/21 download Created with Sketch. 24.69KB
ALA Proposed issue of securities - SUD22/06/21 download Created with Sketch. 28.42KB
ALA Disclosure Document Prospectus $3.65mPRICE SENSITIVE22/06/21 download Created with Sketch. 441.67KB
ALA Proposed issue of securities - SUD22/06/21 download Created with Sketch. 25.21KB
ALA SUDA Placement Raises $3.65mPRICE SENSITIVE22/06/21 download Created with Sketch. 204.87KB
ALA Investor Webinar18/06/21 download Created with Sketch. 145.22KB
ALA Investor Presentation incorporating iNKT Cell PlatformPRICE SENSITIVE18/06/21 download Created with Sketch. 2.94MB
ALA SUDA Licenses a Novel iNKT Cell Therapy PlatformPRICE SENSITIVE18/06/21 download Created with Sketch. 224.1KB
ALA Trading HaltPRICE SENSITIVE18/06/21 download Created with Sketch. 336.65KB
ALA Quarterly Appendix 4C and Activities ReportPRICE SENSITIVE27/04/21 download Created with Sketch. 342.76KB
ALA Anagrelide Project Update07/04/21 download Created with Sketch. 185.51KB
ALA Investor Presentation March 2021PRICE SENSITIVE30/03/21 download Created with Sketch. 1.88MB
ALA Newsletter March 202129/03/21 download Created with Sketch. 181.14KB
ALA Anagrelide Project Update29/03/21 download Created with Sketch. 187.3KB
ALA Appendix 3G03/03/21 download Created with Sketch. 294.38KB
ALA Anagrelide Project UpdatePRICE SENSITIVE26/02/21 download Created with Sketch. 186.82KB
ALA Appendix 4D & Interim Financial Half Year Report FY2021PRICE SENSITIVE26/02/21 download Created with Sketch. 806.08KB
ALA Change of Director's Interest Notice16/02/21 download Created with Sketch. 164.95KB
ALA Change of Director's Interest Notice16/02/21 download Created with Sketch. 166.3KB
ALA Change of Director's Interest Notice16/02/21 download Created with Sketch. 166.5KB
ALA Appendix 2A16/02/21 download Created with Sketch. 333.56KB
ALA Zelira Therapeutics Feasibility Study UpdatePRICE SENSITIVE16/02/21 download Created with Sketch. 181.43KB
ALA Results of General Meeting29/01/21 download Created with Sketch. 709.35KB
ALA GM presentationPRICE SENSITIVE29/01/21 download Created with Sketch. 1.73MB
ALA Quarterly Appendix 4C and Activities ReportPRICE SENSITIVE25/01/21 download Created with Sketch. 395.51KB
ALA Zolpimist UpdatePRICE SENSITIVE25/01/21 download Created with Sketch. 201.14KB
ALA Suda Update18/01/21 download Created with Sketch. 184.19KB
ALA Notice of EGM and Proxy form24/12/20 download Created with Sketch. 528.22KB
ALA Placement Offer Completed and Appendix 2A22/12/20 download Created with Sketch. 421.4KB
ALA Proposed issue of Securities - SUD22/12/20 download Created with Sketch. 24.86KB
ALA Company Update - Letter to ShareholdersPRICE SENSITIVE22/12/20 download Created with Sketch. 201.39KB
ALA Proposed issue of Securities - SUD16/12/20 download Created with Sketch. 24.87KB
ALA Proposed issue of Securities - SUD16/12/20 download Created with Sketch. 25.13KB
ALA Prospectus - PlacementPRICE SENSITIVE16/12/20 download Created with Sketch. 525.7KB
ALA Placement Offer to raise $2.76mPRICE SENSITIVE16/12/20 download Created with Sketch. 199.74KB
ALA Ordesa Feasibility Study UpdatePRICE SENSITIVE16/12/20 download Created with Sketch. 182.05KB
ALA Trading HaltPRICE SENSITIVE14/12/20 download Created with Sketch. 336.51KB
ALA SUD Constitution (amended)26/11/20 download Created with Sketch. 417.61KB
ALA Results of Annual General Meeting26/11/20 download Created with Sketch. 762.58KB
ALA AGM FY20 Chairman's address and virtual meeting guidePRICE SENSITIVE26/11/20 download Created with Sketch. 599.16KB
ALA AGM FY20 PresentationPRICE SENSITIVE26/11/20 download Created with Sketch. 1.19MB
ALA R & D Tax Incentive refund receivedPRICE SENSITIVE24/11/20 download Created with Sketch. 184.04KB
ALA Investor Presentation November 2020PRICE SENSITIVE17/11/20 download Created with Sketch. 1.51MB
ALA Change of Director's Interest Notice - P. Hopper11/11/20 download Created with Sketch. 165.23KB
ALA Change of Director's Interest Notice - D.Simmonds09/11/20 download Created with Sketch. 164.79KB
ALA Change of Director's Interest Notice28/10/20 download Created with Sketch. 166.48KB
ALA Notice of General Meeting/Proxy Form27/10/20 download Created with Sketch. 710.15KB
ALA Quarterly Appendix 4C and Activities ReportPRICE SENSITIVE26/10/20 download Created with Sketch. 421.45KB
ALA Appendix 2A16/10/20 download Created with Sketch. 421.15KB
ALA Proposed issue of Securities - SUD16/10/20 download Created with Sketch. 26.5KB
ALA Notice of 2020 Annual General Meeting08/10/20 download Created with Sketch. 176.76KB
ALA Newsletter October 202008/10/20 download Created with Sketch. 181.61KB
ALA Appendix 4G and FY20 Corporate Governance Statement25/09/20 download Created with Sketch. 588.24KB
ALA FY20 Annual Report to shareholders25/09/20 download Created with Sketch. 4.3MB
ALA Anagrelide Project UpdatePRICE SENSITIVE22/09/20 download Created with Sketch. 223.6KB
ALA Anagrelide Cancer Patent For AustraliaPRICE SENSITIVE08/09/20 download Created with Sketch. 195.4KB
ALA Preliminary Final ReportPRICE SENSITIVE31/08/20 download Created with Sketch. 308.63KB
ALA Company Secretary18/08/20 download Created with Sketch. 182.48KB
ALA Placement Offer Completed and Appendix 2A10/08/20 download Created with Sketch. 469.67KB
ALA Change of Director's Interest Notice07/08/20 download Created with Sketch. 302.7KB
ALA Distribution of Security Holders05/08/20 download Created with Sketch. 204.19KB
ALA ProspectusPRICE SENSITIVE05/08/20 download Created with Sketch. 460.51KB
ALA Top 20 securityholders05/08/20 download Created with Sketch. 191.21KB
ALA Ceasing to be a substantial holder05/08/20 download Created with Sketch. 167.67KB
ALA Entitlement Offer Completed and Appendix 2A05/08/20 download Created with Sketch. 472.31KB
ALA Proposed issue of Securities - SUD03/08/20 download Created with Sketch. 24.76KB
ALA Becoming a substantial holder03/08/20 download Created with Sketch. 54.25KB
ALA Entitlement Offer Closes Significantly Oversubscribed03/08/20 download Created with Sketch. 197.81KB
ALA Appendix 4C - quarterlyPRICE SENSITIVE31/07/20 download Created with Sketch. 372.54KB
ALA TGA Approval Granted For ZolpiMistPRICE SENSITIVE29/07/20 download Created with Sketch. 198.57KB
ALA Update - Proposed issue of Securities - SUD16/07/20 download Created with Sketch. 35.55KB
ALA Extension Of Offer Closing Date16/07/20 download Created with Sketch. 194.9KB
ALA Initial Director's Interest Notice03/07/20 download Created with Sketch. 136.94KB
ALA Investor Presentation03/07/20 download Created with Sketch. 1.53MB
ALA Notice To Option Holders03/07/20 download Created with Sketch. 149.42KB
ALA Notice To Eligible Shareholders03/07/20 download Created with Sketch. 194.73KB
ALA Notice To Ineligible Shareholders03/07/20 download Created with Sketch. 187.05KB
ALA Proposed issue of Securities - SUD03/07/20 download Created with Sketch. 35.9KB
ALA Prospectus For Entitlement OfferPRICE SENSITIVE03/07/20 download Created with Sketch. 565.08KB
ALA Entitlement Offer To Raise Approximately $3.56 MillionPRICE SENSITIVE03/07/20 download Created with Sketch. 224.47KB
ALA Joint Company Secretary and Change of Registered Office01/07/20 download Created with Sketch. 179.83KB
ALA SUDA Appoints Dr Baker As Director29/06/20 download Created with Sketch. 180.66KB
ALA Reinstatement to Official QuotationPRICE SENSITIVE25/06/20 download Created with Sketch. 213.5KB
ALA Market UpdatePRICE SENSITIVE25/06/20 download Created with Sketch. 183.02KB
ALA Suspension from Official QuotationPRICE SENSITIVE05/06/20 download Created with Sketch. 346.98KB
ALA Trading HaltPRICE SENSITIVE01/06/20 download Created with Sketch. 330.17KB
ALA Pause in TradingPRICE SENSITIVE01/06/20 download Created with Sketch. 115.5KB
ALA Anagrelide Project Update27/05/20 download Created with Sketch. 189.49KB
ALA Dr John Maher Appointed to SUDA iNKT Cell Therapy SAB
03/09/21 download Created with Sketch. 147.85KB
ALA Preliminary Final Report
31/08/21PRICE SENSITIVE download Created with Sketch. 291.67KB
ALA Dr Reuben Benjamin Appointed to SUDA iNKT Cell Therapy SAB
26/08/21PRICE SENSITIVE download Created with Sketch. 171.78KB
ALA SUDA signs Licence and Distribution Agreement with STADA
24/08/21PRICE SENSITIVE download Created with Sketch. 202.74KB
ALA ZolpiMist Update
23/08/21PRICE SENSITIVE download Created with Sketch. 143.74KB
ALA iNKT cell therapy platform update
16/08/21PRICE SENSITIVE download Created with Sketch. 178.02KB
ALA Initial Director's Interest Notice
12/08/21 download Created with Sketch. 136KB
ALA Appointment of Dr Debora Barton as Non-Executive Director
10/08/21 download Created with Sketch. 148.16KB
ALA SUDA appoints new cell and gene therapy manufacturing expert
02/08/21PRICE SENSITIVE download Created with Sketch. 218.78KB
ALA SUDA to present at NWR Virtual Investor Conference
29/07/21 download Created with Sketch. 148.09KB
ALA Quarterly Appendix 4C and Activities Report
26/07/21PRICE SENSITIVE download Created with Sketch. 305.08KB
ALA Notification regarding unquoted securities - SUD
13/07/21 download Created with Sketch. 37.64KB
ALA Application for quotation of securities - SUD
29/06/21 download Created with Sketch. 24.69KB
ALA Proposed issue of securities - SUD
22/06/21 download Created with Sketch. 28.42KB
ALA Disclosure Document Prospectus $3.65m
22/06/21PRICE SENSITIVE download Created with Sketch. 441.67KB
ALA Proposed issue of securities - SUD
22/06/21 download Created with Sketch. 25.21KB
ALA SUDA Placement Raises $3.65m
22/06/21PRICE SENSITIVE download Created with Sketch. 204.87KB
ALA Investor Webinar
18/06/21 download Created with Sketch. 145.22KB
ALA Investor Presentation incorporating iNKT Cell Platform
18/06/21PRICE SENSITIVE download Created with Sketch. 2.94MB
ALA SUDA Licenses a Novel iNKT Cell Therapy Platform
18/06/21PRICE SENSITIVE download Created with Sketch. 224.1KB
ALA Trading Halt
18/06/21PRICE SENSITIVE download Created with Sketch. 336.65KB
ALA Quarterly Appendix 4C and Activities Report
27/04/21PRICE SENSITIVE download Created with Sketch. 342.76KB
ALA Anagrelide Project Update
07/04/21 download Created with Sketch. 185.51KB
ALA Investor Presentation March 2021
30/03/21PRICE SENSITIVE download Created with Sketch. 1.88MB
ALA Newsletter March 2021
29/03/21 download Created with Sketch. 181.14KB
ALA Anagrelide Project Update
29/03/21 download Created with Sketch. 187.3KB
ALA Appendix 3G
03/03/21 download Created with Sketch. 294.38KB
ALA Anagrelide Project Update
26/02/21PRICE SENSITIVE download Created with Sketch. 186.82KB
ALA Appendix 4D & Interim Financial Half Year Report FY2021
26/02/21PRICE SENSITIVE download Created with Sketch. 806.08KB
ALA Change of Director's Interest Notice
16/02/21 download Created with Sketch. 164.95KB
ALA Change of Director's Interest Notice
16/02/21 download Created with Sketch. 166.3KB
ALA Change of Director's Interest Notice
16/02/21 download Created with Sketch. 166.5KB
ALA Appendix 2A
16/02/21 download Created with Sketch. 333.56KB
ALA Zelira Therapeutics Feasibility Study Update
16/02/21PRICE SENSITIVE download Created with Sketch. 181.43KB
ALA Results of General Meeting
29/01/21 download Created with Sketch. 709.35KB
ALA GM presentation
29/01/21PRICE SENSITIVE download Created with Sketch. 1.73MB
ALA Quarterly Appendix 4C and Activities Report
25/01/21PRICE SENSITIVE download Created with Sketch. 395.51KB
ALA Zolpimist Update
25/01/21PRICE SENSITIVE download Created with Sketch. 201.14KB
ALA Suda Update
18/01/21 download Created with Sketch. 184.19KB
ALA Notice of EGM and Proxy form
24/12/20 download Created with Sketch. 528.22KB
ALA Placement Offer Completed and Appendix 2A
22/12/20 download Created with Sketch. 421.4KB
ALA Proposed issue of Securities - SUD
22/12/20 download Created with Sketch. 24.86KB
ALA Company Update - Letter to Shareholders
22/12/20PRICE SENSITIVE download Created with Sketch. 201.39KB
ALA Proposed issue of Securities - SUD
16/12/20 download Created with Sketch. 24.87KB
ALA Proposed issue of Securities - SUD
16/12/20 download Created with Sketch. 25.13KB
ALA Prospectus - Placement
16/12/20PRICE SENSITIVE download Created with Sketch. 525.7KB
ALA Placement Offer to raise $2.76m
16/12/20PRICE SENSITIVE download Created with Sketch. 199.74KB
ALA Ordesa Feasibility Study Update
16/12/20PRICE SENSITIVE download Created with Sketch. 182.05KB
ALA Trading Halt
14/12/20PRICE SENSITIVE download Created with Sketch. 336.51KB
ALA SUD Constitution (amended)
26/11/20 download Created with Sketch. 417.61KB
ALA Results of Annual General Meeting
26/11/20 download Created with Sketch. 762.58KB
ALA AGM FY20 Chairman's address and virtual meeting guide
26/11/20PRICE SENSITIVE download Created with Sketch. 599.16KB
ALA AGM FY20 Presentation
26/11/20PRICE SENSITIVE download Created with Sketch. 1.19MB
ALA R & D Tax Incentive refund received
24/11/20PRICE SENSITIVE download Created with Sketch. 184.04KB
ALA Investor Presentation November 2020
17/11/20PRICE SENSITIVE download Created with Sketch. 1.51MB
ALA Change of Director's Interest Notice - P. Hopper
11/11/20 download Created with Sketch. 165.23KB
ALA Change of Director's Interest Notice - D.Simmonds
09/11/20 download Created with Sketch. 164.79KB
ALA Change of Director's Interest Notice
28/10/20 download Created with Sketch. 166.48KB
ALA Notice of General Meeting/Proxy Form
27/10/20 download Created with Sketch. 710.15KB
ALA Quarterly Appendix 4C and Activities Report
26/10/20PRICE SENSITIVE download Created with Sketch. 421.45KB
ALA Appendix 2A
16/10/20 download Created with Sketch. 421.15KB
ALA Proposed issue of Securities - SUD
16/10/20 download Created with Sketch. 26.5KB
ALA Notice of 2020 Annual General Meeting
08/10/20 download Created with Sketch. 176.76KB
ALA Newsletter October 2020
08/10/20 download Created with Sketch. 181.61KB
ALA Appendix 4G and FY20 Corporate Governance Statement
25/09/20 download Created with Sketch. 588.24KB
ALA FY20 Annual Report to shareholders
25/09/20 download Created with Sketch. 4.3MB
ALA Anagrelide Project Update
22/09/20PRICE SENSITIVE download Created with Sketch. 223.6KB
ALA Anagrelide Cancer Patent For Australia
08/09/20PRICE SENSITIVE download Created with Sketch. 195.4KB
ALA Preliminary Final Report
31/08/20PRICE SENSITIVE download Created with Sketch. 308.63KB
ALA Company Secretary
18/08/20 download Created with Sketch. 182.48KB
ALA Placement Offer Completed and Appendix 2A
10/08/20 download Created with Sketch. 469.67KB
ALA Change of Director's Interest Notice
07/08/20 download Created with Sketch. 302.7KB
ALA Distribution of Security Holders
05/08/20 download Created with Sketch. 204.19KB
ALA Prospectus
05/08/20PRICE SENSITIVE download Created with Sketch. 460.51KB
ALA Top 20 securityholders
05/08/20 download Created with Sketch. 191.21KB
ALA Ceasing to be a substantial holder
05/08/20 download Created with Sketch. 167.67KB
ALA Entitlement Offer Completed and Appendix 2A
05/08/20 download Created with Sketch. 472.31KB
ALA Proposed issue of Securities - SUD
03/08/20 download Created with Sketch. 24.76KB
ALA Becoming a substantial holder
03/08/20 download Created with Sketch. 54.25KB
ALA Entitlement Offer Closes Significantly Oversubscribed
03/08/20 download Created with Sketch. 197.81KB
ALA Appendix 4C - quarterly
31/07/20PRICE SENSITIVE download Created with Sketch. 372.54KB
ALA TGA Approval Granted For ZolpiMist
29/07/20PRICE SENSITIVE download Created with Sketch. 198.57KB
ALA Update - Proposed issue of Securities - SUD
16/07/20 download Created with Sketch. 35.55KB
ALA Extension Of Offer Closing Date
16/07/20 download Created with Sketch. 194.9KB
ALA Initial Director's Interest Notice
03/07/20 download Created with Sketch. 136.94KB
ALA Investor Presentation
03/07/20 download Created with Sketch. 1.53MB
ALA Notice To Option Holders
03/07/20 download Created with Sketch. 149.42KB
ALA Notice To Eligible Shareholders
03/07/20 download Created with Sketch. 194.73KB
ALA Notice To Ineligible Shareholders
03/07/20 download Created with Sketch. 187.05KB
ALA Proposed issue of Securities - SUD
03/07/20 download Created with Sketch. 35.9KB
ALA Prospectus For Entitlement Offer
03/07/20PRICE SENSITIVE download Created with Sketch. 565.08KB
ALA Entitlement Offer To Raise Approximately $3.56 Million
03/07/20PRICE SENSITIVE download Created with Sketch. 224.47KB
ALA Joint Company Secretary and Change of Registered Office
01/07/20 download Created with Sketch. 179.83KB
ALA SUDA Appoints Dr Baker As Director
29/06/20 download Created with Sketch. 180.66KB
ALA Reinstatement to Official Quotation
25/06/20PRICE SENSITIVE download Created with Sketch. 213.5KB
ALA Market Update
25/06/20PRICE SENSITIVE download Created with Sketch. 183.02KB
ALA Suspension from Official Quotation
05/06/20PRICE SENSITIVE download Created with Sketch. 346.98KB
ALA Trading Halt
01/06/20PRICE SENSITIVE download Created with Sketch. 330.17KB
ALA Pause in Trading
01/06/20PRICE SENSITIVE download Created with Sketch. 115.5KB
ALA Anagrelide Project Update
27/05/20 download Created with Sketch. 189.49KB
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
(20min delay)
Last
9.9¢
Change
-0.006(5.71%)
Mkt cap ! $118.1M
Open High Low Value Volume
10.5¢ 10.5¢ 9.9¢ $100.7K 1.007M

Buyers (Bids)

No. Vol. Price($)
7 181339 9.8¢
 

Sellers (Offers)

Price($) Vol. No.
10.5¢ 491674 9
View Market Depth
Last trade - 13.03pm 11/08/2025 (20 minute delay) ?
Last
9.9¢
  Change
-0.006 ( 1.00 %)
Open High Low Volume
10.5¢ 10.5¢ 9.9¢ 659596
Last updated 13.39pm 11/08/2025 ?
ALA (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.